Premature IP Action Over Kennedy Trust's Remicade Tossed
The Kennedy Trust for Rheumatology Research on Monday escaped a suit from a drugmaker that sought to have the court declare that its biosimilar arthritis medicine didn't infringe Kennedy's patents for...To view the full article, register now.
Already a subscriber? Click here to view full article